Recent Articles

December 2, 2016 3:58 pm
Ryan Bushey
Heather Bresch came to the fifth annual Forbes Healthcare conference to talk about the fallout from the EpiPen pricing controversy.
November 30, 2016 8:32 am
Ryan Bushey
This condition produces mutations that lead to a serious shortage of white blood cells.
November 30, 2016 9:46 am
James Beggs, Ph.D., Oncology and Hematology Analyst, GlobalData
The myelofibrosis market is expected to almost double in value from $545.2 million in 2015 to $1.02 billion by 2025, representing a compound annual growth rate of 6.4%.
November 29, 2016 9:58 am
Ryan Bushey
Approximately 400,000 people all over the world are living with either hemophilia A or hemophilia B.
November 28, 2016 12:00 pm
Deekshita Allavaparapu, Analyst, GBI Research
North America remains the largest regional market for drug delivery technologies, with the US accounting for the largest market in terms of value and volume.
November 28, 2016 8:50 am
Ryan Bushey
An experimental Alzheimer’s drug being developed by Eli Lilly failed to slow cognitive decline in patients with even a mild form of the condition.
November 22, 2016 9:57 am
Adam Bradbury, Associate Analyst, GBI Research
Generic penetration is currently non-existent in the cancer vaccines market, further aiding market growth.
November 21, 2016 4:02 pm
Ryan Bushey
Novartis is boosting its hematology pipeline with a new acquisition.
November 21, 2016 8:26 am
Jessie Schanzle, Desk Editor, Health and Medicine, The Conversation
More people died from drug overdose in 2014 than in any other year, and six in 10 of those deaths involved an opioid, such as a painkiller or heroin.
November 17, 2016 10:01 am
Ryan Bushey
Amgen and Novartis are one step closer to having a contender in the migraine treatment space.
Subscribe to Drug Discovery & Development